Physician profile
Robert C Raley
NPI 1154460590
$1,149.55
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $658 · 2020: $291 · 2021: $35.76 · 2022: $129 · 2023: $19.30 · 2024: $17.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $36.80.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $36.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $239.30 | 2019 | |
| Novo Nordisk INC | $188.46 | 2019-2020 | |
| Glaxosmithkline, LLC. | $155.36 | 2019-2023 | Shingrix |
| Pfizer INC. | $120.21 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $109.25 | 2019 | |
| Allergan, INC. | $89.44 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $56.58 | 2020-2021 | |
| Abbvie INC. | $53.46 | 2020-2022 | |
| Astellas Pharma US INC | $22.77 | 2019 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $22.64 | 2022 | |
| Amarin Pharma, INC. | $19.76 | 2020 | |
| Abbott Laboratories | $17.50 | 2024 | Proclaim |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.66 | 2019 | |
| Sanofi Pasteur INC. | $13.66 | 2019 | |
| Aytu Biopharma, INC. | $12.45 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $12.05 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Raley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.